Lion's Mane
SupplementThe medical score (55) is lower than the community score (72) because clinical studies show small sample sizes and mixed results [s6, s10], while community users subjectively perceive stronger and more consistent effects [c1, c2]. This divergence is typical for nootropics, where placebo effects and expectation bias may play a significant role [s10].
Unlock full information
Dosages, side effects, studies and more — free after registration.
Register for freeRating Scales
TL;DR
Lion's Mane is the best-evidenced medicinal mushroom for cognitive health: five RCTs (n≥197) show effects on memory, mood, and NGF synthesis, though effect sizes remain moderate. Product form is critical — fruiting body extracts deliver hericenones, mycelium extracts deliver erinacines, and many cheap products contain barely any active compounds. Mycelium-based products are not legally marketable in the EU without Novel Food approval — a point most vendors quietly ignore. With quality sourcing and 4–8 weeks of patience, expectations are realistic.
Description
Medicinal edible mushroom with neuroprotective properties; promotes NGF synthesis and is investigated for cognitive function, mood, and neuroregeneration [s1, s2, s3].
Hericium erinaceus (lion's mane) is an edible medicinal mushroom traditionally used in Chinese medicine for digestive complaints and nerve strengthening [s15]. It contains two main classes of bioactive compounds: hericenones (from the fruiting body) and erinacines (from the mycelium), both of which can stimulate endogenous synthesis of nerve growth factor (NGF) [s1, s3]. Additionally, the mushroom contains beta-glucan polysaccharides, sterols, and further terpenoids with immunomodulatory and antioxidant properties [s4, s5]. Human clinical studies have so far focused primarily on mild cognitive impairment (MCI), mood disorders, and neuroprotection. A double-blind, placebo-controlled RCT with 30 patients with MCI demonstrated significant cognitive improvements after 16 weeks, which reversed upon discontinuation [s6]. A further RCT with 77 overweight adults reported improvements in anxiety, depression, and sleep disturbances [s7]. A small RCT in healthy young adults (n=41) showed acute improvements in specific cognitive tests and mood parameters [s8]. A study with patients with mild Alzheimer's disease (n=49, 49 weeks) demonstrated significant improvements in IADL scores under erinacine-A-enriched mycelium [s9]. The overall evidence is promising but still limited: most human studies are small (n<100), and many findings are based on animal or in vitro models. A 2024 systematic review found mixed results across intervention studies [s10].
Legal Status (DE)
Fruiting body extracts and powders of Hericium erinaceus are considered traditional foods in the EU and Germany and are approved as dietary supplements. Mycelium preparations (e.g., fermented mycelium), however, fall under EU Novel Food Regulation (EU) 2015/2283 and are not marketable in foods and dietary supplements without authorization. In the EU Novel Food Catalogue, Hericium erinaceus is listed as a traditional food for fruiting body preparations, while mycelium preparations require authorization. Source: European Commission, Novel Food Catalogue (2023). source_ids: - s14 - s19
Mechanism of Action
The primary mechanisms of action of Hericium erinaceus are: 1. NGF induction: Hericenones (C, D, E, F, G, H, I) from the fruiting body and erinacines (A–K and others) from the mycelium stimulate endogenous NGF synthesis in astrocytes and neurons [s1, s3]. NGF promotes the survival, growth, and differentiation of cholinergic neurons. Erinacine A can cross the blood-brain barrier (BBB) due to its lipophilic nature [s3]. Hericenones, by contrast, may cross the BBB less efficiently [s3]. 2. Neurite outgrowth: Extracts stimulate neurite (axon and dendrite) outgrowth in vitro, suggesting neuroregenerative properties [s1, s4]. 3. Neuroprotective mechanisms: Antioxidant and anti-inflammatory effects protect neurons from oxidative stress and neuroinflammation, including through inhibition of NF-κB and reduction of pro-inflammatory cytokines [s3, s5]. 4. Immunomodulation: Beta-glucan polysaccharides activate immune cells (macrophages, NK cells, dendritic cells) via Dectin-1 receptors and modulate the intestinal immune system [s4, s5]. 5. Hippocampal neurogenesis (preclinical): Chronic administration in mice promoted hippocampal neurogenesis and exhibited anxiolytic and antidepressant effects, possibly via BDNF signaling pathways [s11]. The bioavailability of the active compounds has not yet been fully elucidated; lipophilic erinacines exhibit greater BBB permeability than hydrophilic beta-glucans [s3].
Dosing
Kognitive Funktion / MCI
- Dose
- 3000 mg fruiting body powder (or 250–500 mg 8:1 extract)
- Frequency
- 3× täglich
- Route
- oral
- Duration
- 16–49 Wochen
- Timing
- With meals
- With food
- empfohlen
Stimmung / Angst / Schlaf
- Dose
- 3× 400 mg capsules daily (equivalent to 1200 mg fruiting body extract)
- Frequency
- 3× täglich
- Route
- oral
- Duration
- 8 Wochen
- Timing
- With meals
- With food
- empfohlen
Akute kognitive Effekte / gesunde Erwachsene
- Dose
- 1800 mg standardized extract
- Frequency
- 1× täglich
- Route
- oral
- Duration
- 28 Tage (auch akute Einzeldosis untersucht)
- Timing
- In the morning
- With food
- optional
In clinical studies, up to 3000 mg of fruiting body powder daily over 16 weeks was used without serious adverse effects [s6]. For mycelium extract (erinacine A-enriched), 1050 mg daily (3× 350 mg) was tolerated over 49 weeks [s9]. No generally recognized Tolerable Upper Intake Level exists; manufacturers typically recommend 500–3000 mg/day depending on form and standardization.
Fruiting body extracts primarily contain hericenones and beta-glucans; mycelium extracts contain erinacines. Biological activity differs depending on the source [s1, s3]. For standardized extracts (e.g., 8:1 or standardized to polysaccharide content), lower gram amounts are equivalent to higher powder amounts.
Side Effects
| Side Effect | Frequency | Severity |
|---|---|---|
| Allergic reaction | selten | leicht |
Contraindications
Interactions
Synergistic
Theoretical synergy through complementary mechanisms (NGF promotion vs. adaptogenic stress reduction); no RCT data available.
Bacopa monnieri improves acetylcholine transmission and synaptic plasticity, while lion's mane promotes NGF production and neurogenesis. These complementary mechanisms may mutually reinforce each other, resulting in more comprehensive cognitive support.
Ashwagandha reduces cortisol and stress, while lion's mane supports neurogenesis and neuroprotective processes. The combination may lead to improved focus, memory, and overall cognitive performance.
Alpha-GPC provides bioavailable choline for acetylcholine synthesis and supports cell-surface receptors for nerve growth factor. Combined with lion's mane, which stimulates NGF production, a synergistic support of the cholinergic system may result.
Citicoline increases acetylcholine and phosphatidylcholine levels in the brain, while lion's mane promotes NGF-mediated neurogenesis. This combination provides comprehensive cognitive support through complementary mechanisms.
Reishi exerts immunomodulatory and stress-reducing effects, while lion's mane supports cognitive function and nerve growth. The combination is used traditionally and in modern nootropic stacks for mental clarity without overstimulation.
Cordyceps promotes ATP production and physical endurance, while lion's mane targets cognitive function and neurogenesis. As part of a medicinal mushroom complex, both fungi synergistically complement each other with distinct activity profiles.
Chaga provides potent antioxidants and cytoprotection, while lion's mane promotes neurogenesis and cognitive function. The combination of both medicinal mushrooms may offer comprehensive protection against oxidative stress in the brain.
Phosphatidylserine supports the structural integrity of brain cell membranes and neurotransmitter function, while lion's mane promotes the growth of new brain cells via NGF. This combination is used for comprehensive cognitive support.
Curcumin exerts anti-inflammatory and neuroprotective effects through NF-κB inhibition; lion's mane promotes neurogenesis via NGF. The combination may produce a more comprehensive neuroprotective effect, with liposomal curcumin optimizing bioavailability.
Caution
Beta-glucans may stimulate the immune system and thereby attenuate the effects of immunosuppressants; close medical monitoring is required [s4, s5].
Theoretical risk of increased bleeding tendency due to possible antiplatelet properties of mushroom extracts; individual case reports, no RCT evidence [s12].
Blood glucose-lowering effects have been observed in animal studies; concurrent use with antidiabetic agents could theoretically increase the risk of hypoglycemia [s5].
Studies
Tier A — High Evidence
Outcome: Cognitive test performance (Hasegawa Dementia Scale)
Effect Size: Significant improvement in the verum group (p<0.001); regression following discontinuation of intervention
Outcome: Mood disorders (anxiety, depression, sleep quality)
Effect Size: Significant reduction in anxiety and depressive mood, and improvement in sleep quality compared to placebo
Outcome: Cognitive tests, mood, stress in healthy young adults
Effect Size: Acute improvement in stress parameters and individual cognitive tests; chronic effects less pronounced
Outcome: IADL score in mild Alzheimer's disease
Effect Size: Significant improvement in IADL score compared to placebo (p<0.05)
Tier B — Moderate Evidence
Outcome: Mood and neurocognitive health through mushroom supplementation
Effect Size: Mixed results; only lion's mane showed potential benefits for cognition and mood, particularly in older adults and at higher doses
Outcome: Overview of safety and clinical efficacy
Effect Size: Positive indications of neuroprotective and immunomodulatory effects; overall quality of evidence rated as moderate
Tier C — Low Evidence
Outcome: Hippocampal neurogenesis, anxiety and depression behavior
Effect Size: Significant increase in neurogenesis; anxiolytic and antidepressant effects under chronic HE administration
Outcome: NGF induction by hericenones and erinacines
Effect Size: Concentration-dependent NGF stimulation demonstrated in cell culture
Community Evidence
Top reported benefits
- Improved mental clarity and focus
- Reduction of brain fog
- Better mood and reduced anxiety
- Improved concentration in ADHD-like symptoms
- Potential support for Long COVID-related cognitive impairment
Top reported issues
- No noticeable effect in a subset of users
- Sleep disturbances and restlessness with evening administration
- Anxiety or palpitations in some users
- Variable product quality and unclear standardization
- High cost of high-quality extracts
Isolated reports of anxiety and sleep disturbances that resolved upon discontinuation [c4]. Product quality varies considerably; mycelium-based products may contain fewer hericenones than fruiting body extracts [c3]. In some users, effects only became apparent after several weeks of use [c1, c2]. The quality question of fruiting body vs. mycelium is extensively debated.
Scientific Sources
- Bioactive substances in Hericium erinaceus and their biological properties: a review
Łysakowska P, Sobota A, Wirkijowska A (2023). International Journal of Molecular Sciences / ScienceDirectBDOI - A review of the effects of mushrooms on mood and neurocognitive health across the lifespan
Martínez-Mármol R, Chai YJ, Bhatt DL, et al. (2024). Neuroscience and Biobehavioral Reviews (ScienceDirect)ADOI - Hericium erinaceus Extract Reduces Anxiety and Depressive Behaviors by Promoting Hippocampal Neurogenesis in the Adult Mouse Brain
Ryu S, Kim HG, Kim JY, et al. (2018). PubMed / Biomedical ResearchCPMID:29091526DOI - Lion's Mane Side Effects and Safety Profile
Teelixir Editorial (2023). Teelixir Australia (non-peer reviewed)DLink - Hericium erinaceus dehydrated mycelium powder — Novel Food Consultation Status
European Commission DG SANTE (2019). European Commission Food SafetyALink - Novel Food (Neuartige Lebensmittel): Verordnung (EU) 2015/2283
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) (2018). BVL / bvl.bund.deALink - Hericium: Warum der Löwenmähne-Pilz so wertvoll für Ihre Gesundheit ist
BIONUTRA Editorial (2023). BIONUTRA (non-peer reviewed)DLink - Lion's Mane Contraindications: Allergy to Fungi
MushiLab Editorial (2023). MushiLab (non-peer reviewed)DLink - Unveiling the role of erinacines in the neuroprotective effects of Hericium erinaceus: a systematic review in preclinical models
PMC authors (2025). PMCALink - Hericium erinaceum (yamabushitake) extract-induced acute respiratory distress syndrome monitored by serum surfactant proteins
Nakatsugawa M, Takahashi H, Takezawa C, et al. (2003). Internal MedicineCLink - Lion's Mane Mushroom (Hericium erinaceus) — Benefits, side effects and uses
NIH/PMC authors (2025). PMC / National Institutes of HealthBLink - Lion's Mane Mushroom (Hericium erinaceus): A Neuroprotective Fungus with Antioxidant, Anti-Inflammatory, and Antimicrobial Potential — A Narrative Review
Kushairi N, Phan CW, Sabaratnam V, et al. (2025). Nutrients (MDPI)BDOI - Polysaccharides from Hericium erinaceus Fruiting Bodies: Structural Characterization, Immunomodulatory Activity and Mechanism
Ren Z, Qin T, Qiu F, et al. (2022). PMC / Frontiers in NutritionCLink - Hericium erinaceus — A Rich Source of Diverse Bioactive Metabolites
Friedman M (2015). Fungal Biotechnology (FGBT)BLink - Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial
Mori K, Inatomi S, Ouchi K, et al. (2009). Phytotherapy ResearchAPMID:18844328DOI - Hericium erinaceus improves mood and sleep disorders in patients affected by overweight or obesity: could circulating pro-BDNF and BDNF be involved?
Vigna L, Morelli F, Agnelli GM, et al. (2019). Evidence-Based Complementary and Alternative MedicineAPMID:31413233DOI - Acute effects of a standardised extract of Hericium erinaceus (Lion's Mane mushroom) on cognition and mood in healthy younger adults: a double-blind randomised placebo-controlled study
Docherty S, Doughty FL, Smith EF (2023). Frontiers in NutritionADOI - Erinacine A-enriched Hericium erinaceus mycelia delays progression of mild Alzheimer's disease: a double-blind, placebo-controlled, clinical trial
Li IC, Lee LY, Tzeng TT, et al. (2020). Journal of Alzheimer's DiseaseAPMID:32597810DOI
Community Sources
Storage
Unopened
Store in a cool, dry, light-protected location at room temperature (15–25 °C).
Opened
Keep container tightly sealed; avoid moisture and direct sunlight; silica gel packets recommended for powder forms.
Notes
Mushroom extracts may clump in the presence of moisture; shelf life after opening is 6–12 months depending on the manufacturer.